000			01698 a2200517 4500
005			20250512131453.0
264		0	_c19741007
008			197410s 0 0 eng d
022			_a0026-895X
040			_aNLM _beng _cNLM
100	1		_aThut, P D
245	0	0	_aAlpha-amanitin inhibition of mouse brain form II ribonucleic acid polymerase and passive avoidance retention. _h[electronic resource]
260			_bMolecular pharmacology _cJan 1974
300			_a146-54 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAvoidance Learning _xdrug effects
650	0	4	_aBasidiomycota
650	0	4	_aBrain _xcytology
650	0	4	_aCell Nucleus _xenzymology
650	0	4	_aCerebral Ventricles
650	0	4	_aDNA-Directed RNA Polymerases _xantagonists & inhibitors
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHydrolysis
650	0	4	_aIn Vitro Techniques
650	0	4	_aInjections
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aLiver _xcytology
650	0	4	_aMale
650	0	4	_aMemory _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Inbred ICR
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aMycotoxins _xadministration & dosage
650	0	4	_aOligopeptides _xadministration & dosage
650	0	4	_aPeptides, Cyclic _xadministration & dosage
650	0	4	_aPerfusion
650	0	4	_aPolyribosomes _xmetabolism
650	0	4	_aPronase
650	0	4	_aRNA _xisolation & purification
650	0	4	_aSodium Dodecyl Sulfate
650	0	4	_aTask Performance and Analysis
650	0	4	_aTime Factors
700	1		_aLindell, T J
773	0		_tMolecular pharmacology _gvol. 10 _gno. 1 _gp. 146-54
999			_c4861752 _d4861752